期刊文献+

白三烯受体拮抗剂孟鲁司特的研究进展 被引量:72

下载PDF
导出
摘要 孟鲁司特是一种新型高选择性半胱氨酰白三烯 1受体拮抗剂 ,它具有多种生物学作用。在改善肺功能、降低气道高反应性、抑制气道重塑及抗肺纤维化 ,以及对炎症和免疫的影响等诸多方面都发挥重要作用。在其他系统疾病的防治中也有不少报道。目前 ,对白三烯受体拮抗剂的药理作用研究正由器官水平向细胞甚至分子、基因水平发展。孟鲁司特是一种具有多种生物活性、高效、低毒、安全性好的平喘抗炎和抗过敏药 ,具有广阔的应用前景。
出处 《国外医学(药学分册)》 2003年第5期284-287,共4页 Foreign Medical Sciences(Section of Pharmarcy)
  • 相关文献

参考文献23

  • 1Steinshamn S, Sandsund M, Sue-Chu M, et al. Effects of montelukast on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction[J]. Scand J Med Sci Sports , 2002, 12(4):211-217.
  • 2Niewoehner DE. Montelukast improved pulmonary function and asthma-specific quality of life in aspirin-intolerant asthma[J]. ACP J Club, 2002, 137(1):20.
  • 3Zhang J, Yu C, Noonan G, et al. Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability[J]. Clin Ther, 2002, 24(4):574-582.
  • 4Stelmach I, Jerzynska J, Kuna P. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresportsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor ( sIL-2R), IL-4, and soluble intercellular adhesion molecule 1(sICAM-1) in children with asthma[J]. J Allergy Clin Immunol, 2002, 109(2) :257 - 263.
  • 5Dempsey O J, Kennedy G, Lipworth BJ. Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukolriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma [ J ]. J Allergy Clin Immunol, 2002, 109(1):68-74.
  • 6Phipatanakul W, Nowak-Wegrzyn A, Eggleston PA, et al.The efficacy of montelukast in the treatment of cat allergen-induced asthma in children[J]. J Allergy Clin Immunol,2002, 109(5) :794 - 799.
  • 7Henderson WR Jr, Tang LO, Chu SJ, at al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model[J]. Am J Respir Crit Care Med, 2002, 165(1):108- 116.
  • 8Fregonese L, Silvestri M, Sabatini F, et al. Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a CysLT1 receptor-mediated mechanism[J]. Clin Exp Allergy, 2002, 32(5):745 -750.
  • 9Minoguchi K, Kohno Y, Minoguchi H, et al. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast[J]. Chest, 2002, 121 (3):732 - 738.
  • 10Braccioni F, Dorman SC, O'byrne PM, et al. The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects[J]. J Allergy Clin Immunol, 2002, 110(1):96- 101.

同被引文献476

引证文献72

二级引证文献425

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部